MATERIAL EVENT4552.TTSE

JCR Pharmaceuticals: change of representative director

Summary

JCR Pharmaceuticals Co., Ltd. filed an extraordinary report via EDINET on 2026-03-02 09:10 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100XNAG ↗ · PDL1.0 · Not investment advice